Home › Cutaneous T-Cell Lymphoma › Minnesota
Cutaneous T-Cell Lymphoma clinical trials in Minnesota
3 studies for Cutaneous T-Cell Lymphoma are looking for participants at sites in Minnesota.
Cities in Minnesota
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT03017820A Registry for People With T-cell Lymphoma
- Mayo Clinic (Data Collection Only), Rochester
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Q702 for the Treatment of Patients With Hematologic Malignancies
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 10, 2025 · NCT06712810From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.